Discounted Cash Flow Rating

Strong Buy

Return on Equity Rating

Strong Buy

Debt to Equity Rating

Strong Sell

Price to Earnings Rating

Strong Sell

Analyst Rating

Sell

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Buy

Standard Deviation

Strong Sell

Williams %R

Strong Buy

Average Directional Index

Neutral

Insider Trading

Neutral

Wall Street Data Solutions Rating

Neutral

B

Reviva Pharmaceuticals Holdings, Inc. Warrants (RVPHW)

Pharmaceutical Preparations

https://www.revivapharma.com

Reviva Pharmaceuticals Holdings Inc is a clinical-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, respiratory, and metabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, 1) Brilaroxazine (RP5063) which is in clinical development and is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, major depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, and Parkinson's disease psychosis and 2) RP1208.

19925 STEVENS CREEK BLVD., SUITE 100
CUPERTINO, CA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

10/18/2018

Market Cap

21,220,052

Shares Outstanding

22,650,000

Weighted SO

N/A

Total Employees

N/A

Upcoming Earnings

N/A

Similar Tickers

RVPH --.--%

ATNFW --.--%

CLNNW --.--%

LIXTW --.--%

ARTLW --.--%

Beta

-0.0960

Last Div

0.0000

Range

0.083-0.083

Chg

0.0052

Avg Vol

N/A

Mkt Cap

21220052

Exch

NASDAQ

Country

US

Phone

408 501 8881

DCF Diff

-0.2638

DCF

0.9489

Div Yield

0.0000

P/S

0.0000

EV Multiple

-0.4758

P/FV

-1.6017

Div Yield %

0.0000

P/E

-0.4620

PEG

0.0040

Payout

0.0000

Current Ratio

0.4133

Quick Ratio

0.4133

Cash Ratio

0.3815

DSO

0.0000

DIO

0.0000

Op Cycle

0.0000

DPO

0.0000

CCC

0.0000

Gross Margin

0.0000

Op Margin

0.0000

Pretax Margin

0.0000

Net Margin

0.0000

Eff Tax Rate

-0.0007

ROA

-5.4829

ROE

79.5936

ROCE

3.8602

NI/EBT

1.0007

EBT/EBIT

1.0000

EBIT/Rev

0.0000

Debt Ratio

0.0413

D/E

-0.0261

LT Debt/Cap

0.0000

Total Debt/Cap

-0.0268

Int Coverage

-1121.6094

CF/Debt

-59.6343

Equity Multi

-0.6323

Rec Turnover

0.0000

Pay Turnover

0.0000

Inv Turnover

0.0000

FA Turnover

0.0000

Asset Turnover

0.0000

OCF/Share

-0.6077

FCF/Share

-0.6077

Cash/Share

0.2277

OCF/Sales

0.0000

FCF/OCF

1.0000

CF Coverage

-59.6343

ST Coverage

-59.6343

CapEx Coverage

0.0000

Div&CapEx Cov

0.0000

P/BV

-1.6017

P/B

-1.6017

P/S

0.0000

P/E

-0.4620

P/FCF

-1.4045

P/OCF

-1.0284

P/CF

-1.0284

PEG

0.0040

P/S

0.0000

EV Multiple

-0.4758

P/FV

-1.6017

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Dec 16, 22:18 Reviva Announces Proposed Public Offering

Revenue Product Segmentation